Table I Index
Table of Contents
|
Table I - 47 Lawrence Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 243 | 417.7 | 131 | 511.6 | 112 | 351.6 |
| Oral cavity and pharynx | * | # | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 55 | 90.4 | 30 | 113.8 | 25 | 71.9 |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 34 | 55.7 | 17 | 63.9** | 17 | 51.1** |
| Rectum and rectosigmoid | 9 | 15.5** | 7 | 26.8** | * | # |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | * | # | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 38 | 62.4 | 24 | 92.9 | 14 | 40.7** |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 34 | 55.4 | 22 | 84.4 | 12 | 35.2** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 10 | 19.3** | 6 | 26.2** | * | # |
| Melanoma of the skin | 9 | 17.6** | 6 | 26.2** | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 26 | 46.1 | * | # | 26 | 86.6 |
| Female genital system | 22 | 38.7 | -- | -- | 22 | 70.9 |
| Cervix uteri | * | # | -- | -- | * | # |
| Corpus uteri | 11 | 20.4** | -- | -- | 11 | 38.1** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | 7 | 11.6** | -- | -- | 7 | 20.6** |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 40 | 72.0 | 40 | 160.5 | -- | -- |
| Prostate gland | 38 | 68.1 | 38 | 151.9 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 20 | 34.2 | 10 | 38.6** | 10 | 31.3** |
| Urinary bladder | 13 | 21.9** | 9 | 34.5** | * | # |
| Kidney and renal pelvis | 6 | 10.1** | * | # | 5 | 15.1** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | * | # | * | # | * | # |
| Brain | * | # | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 5 | 7.1** | * | # | * | # |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 5 | 7.1** | * | # | * | # |
| Multiple myeloma | 5 | 8.3** | 5 | 19.0** | * | # |
| Leukemia | 8 | 14.3** | * | # | 5 | 16.2** |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 7 | 11.1** | 5 | 18.5** | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||